Get the Stockscreener App
18.04
2.28%
-0.42
After Hours:
18.00
-0.04
-0.22%
Passage Bio Inc stock is traded at $18.04, with a volume of 100.79K.
It is down -2.28% in the last 24 hours and up +95.87% over the past month.
Passage Bio Inc is a genetic medicines company. The company is focused on developing transformative therapies for rare, monogenic CNS disorders. It has pipeline products such as GM1 Gangliosidosis, Frontotemporal dementia, and Krabbe Disease. The Company operates in a single reportable segment, developing and advancing genetic medicines designed to target critical underlying pathology of neurodegenerative diseases.
See More
Previous Close:
$18.46
Open:
$18.58
24h Volume:
100.79K
Relative Volume:
1.92
Market Cap:
$57.34M
Revenue:
-
Net Income/Loss:
$-68.80M
P/E Ratio:
-15.42
EPS:
-1.17
Net Cash Flow:
$-59.06M
1W Performance:
+52.88%
1M Performance:
+95.87%
6M Performance:
+4,066%
1Y Performance:
+2,477%
1-Day Range:
$17.01
$19.25
1-Week Range:
$11.37
$19.25
52-Week Range:
$0.257
$19.25
Passage Bio Inc Stock (PASG) Company Profile
Name
Passage Bio Inc
Sector
Industry
Phone
(267) 866-0312
Address
ONE COMMERCE SQUARE, PHILADELPHIA, PA
Compare PASG with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
PASG
Passage Bio Inc
|
18.04 | 58.68M | 0 | -68.80M | -59.06M | -1.17 |
|
VRTX
Vertex Pharmaceuticals Inc
|
484.15 | 118.84B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
812.27 | 81.61B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
422.50 | 53.69B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
822.94 | 49.49B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
176.00 | 37.34B | 447.02M | -1.18B | -906.14M | -6.1812 |
Passage Bio Inc Stock (PASG) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Nov-29-24 | Resumed | Wedbush | Outperform |
| Sep-03-24 | Initiated | Rodman & Renshaw | Buy |
| Mar-08-22 | Downgrade | JP Morgan | Overweight → Neutral |
| Jan-19-22 | Downgrade | Goldman | Buy → Neutral |
| Jul-01-21 | Initiated | Raymond James | Outperform |
| Jun-15-21 | Initiated | BTIG Research | Buy |
| Mar-04-21 | Upgrade | Goldman | Neutral → Buy |
| Feb-04-21 | Initiated | Guggenheim | Buy |
| Jan-25-21 | Initiated | Wedbush | Outperform |
| Jan-04-21 | Upgrade | JP Morgan | Neutral → Overweight |
| Dec-11-20 | Initiated | Citigroup | Neutral |
| Aug-14-20 | Downgrade | JP Morgan | Overweight → Neutral |
| Jun-25-20 | Downgrade | Goldman | Buy → Neutral |
| Mar-25-20 | Initiated | Chardan Capital Markets | Buy |
| Mar-24-20 | Initiated | Cowen | Outperform |
| Mar-24-20 | Initiated | Goldman | Buy |
| Mar-24-20 | Initiated | JP Morgan | Overweight |
View All
Passage Bio Inc Stock (PASG) Latest News
Candlestick Signal Suggests Reversal in QVC Exports LimitedTrading Volume Surges & Free Tools to Monitor Market Corrections - bollywoodhelpline.com
Aug Highlights: Is Ares Management Corporation stock attractive after correction2025 Retail Activity & Stock Portfolio Risk Management - moha.gov.vn
Passage Bio Reports Promising Data in Trial for Frontotemporal Dementia Treatment - MSN
Quicktouch Technologies Limited Bounces Off Moving Average SupportDividend Stock Watch & Small Investment Big Gains - earlytimes.in
Earnings Chart Overlay Points to Rajesh Power Services Limited UpsideStock Price Divergence & Free Dynamic Capital Growth - bollywoodhelpline.com
Trendlines Converge — Decision Point for Affle (India) LimitedPrice Action Analysis & Free Turn Volatility To Profit - bollywoodhelpline.com
Is Maxposure Limited in Accumulation Phase NowSector ETF Performance & High Return Stock Ideas - bollywoodhelpline.com
Live Scanner Shows Breakout on Paras Defence and Space Technologies LimitedEarnings Volatility Patterns & Big Gains Low Budget - bollywoodhelpline.com
Spright Agro Limited (531205) Gets Regulatory ApprovalCandlestick Pattern Analysis & Set Up Real-Time Alerts – It’s Free - bollywoodhelpline.com
Chartists Watching For Breakout in Nakoda Group of Industries LimitedInstitutional Buying Trends & Consistent High Yield Stocks - bollywoodhelpline.com
Passage Bio Stock: Niche Gene Therapy Player Tests Investor Patience As Wall Street Turns Cautiously - AD HOC NEWS
Passage Bio (PASG) Stock Analysis Report | Financials & Insights - Benzinga
Derivatives Limited Experts SayTrading Volume Trends & Discover Your Financial Freedom Formula - bollywoodhelpline.com
Tara Chand Logistic Solutions Limited Matches Institutional Buying FilterMean Reversion Trades & Fast Profit Trading Tips - bollywoodhelpline.com
Passage Bio Approves 1-for-20 Reverse Stock Split to Maintain Nasdaq Compliance - MSN
Passage Bio Inc Stock Analysis and ForecastMarket Volatility Update & High Profit Investment Ideas - earlytimes.in
KeerthiKumar s Stock PortfolioHigh Beta Stocks & Build Wealth With Strategy - bollywoodhelpline.com
Is Rajasthan Tube Manufacturing Company Limited Starting a New UptrendVolume Profile Analysis & Small Budget Big Profits - bollywoodhelpline.com
Gini Silk Mills Limited Attempts Reversal From Key SupportProtective Put Strategies & Free High Yield Portfolio Picks - bollywoodhelpline.com
Why Passage Bio Inc. stock is rated strong buy2025 Market Overview & Verified Momentum Stock Alerts - Улправда
Why Passage Bio Inc. stock is seen as undervaluedQuarterly Trade Report & Community Verified Watchlist Alerts - Улправда
Will Passage Bio Inc. stock sustain high P E ratiosJuly 2025 Short Interest & High Return Trade Guides - Улправда
Will Passage Bio Inc. stock benefit from green energy trendsJuly 2025 Review & Stepwise Trade Signal Guides - DonanımHaber
Will Passage Bio Inc. stock benefit from sector rotation2025 AllTime Highs & Safe Entry Trade Signal Reports - Улправда
What analyst consensus says on Passage Bio Inc. stockJuly 2025 Outlook & AI Forecasted Stock Moves - Улправда
Passage Bio Earnings Notes - Trefis
Affle (India) Limited Flashes Buy Signal on Multi Timeframe ChartEquity Performance Review & Low Risk Investment Tips - bollywoodhelpline.com
Aug PreEarnings: Is Passage Bio Inc stock a buy on dips2025 Price Momentum & Technical Confirmation Trade Alerts - moha.gov.vn
Financial Comparison: Passage Bio (NASDAQ:PASG) versus PepGen (NASDAQ:PEPG) - Defense World
Passage Bio (PASG) Price Target Increased by 21.85% to 40.39 - Nasdaq
What drives Passage Bio Inc stock priceGrowth Stock Opportunities & Affordable Investment Portfolio - earlytimes.in
How Passage Bio Inc. stock compares to industry benchmarksPortfolio Risk Report & Free Fast Gain Swing Trade Alerts - Newser
Is Passage Bio Inc. stock a safe haven assetMarket Growth Report & Pattern Based Trade Signal System - Newser
Why Passage Bio Inc. stock is a must watch in 2025Market Rally & Free Community Supported Trade Ideas - Newser
Passage Bio to Present at Two Major Investor Conferences - MSN
Gains Recap: Why Passage Bio Inc. stock is seen as undervalued2025 Momentum Check & Free High Accuracy Swing Entry Alerts - moha.gov.vn
How currency fluctuations impact Passage Bio Inc. stockMarket Risk Analysis & Verified Stock Trade Ideas - moha.gov.vn
Risk Off: Will Passage Bio Inc. stock sustain high P E ratiosQuarterly Portfolio Report & Free Technical Confirmation Trade Alerts - moha.gov.vn
Brokerages Set Passage Bio, Inc. (NASDAQ:PASG) Target Price at $42.67 - Defense World
Ocugen CEO to Spotlight Gene Therapy Breakthroughs at High-Profile Growth Conference - MyChesCo
Passage Bio (PASG) Price Target Decreased by 45.15% to 33.15 - MSN
Lucid Capital Markets initiates Passage Bio stock with Buy rating By Investing.com - Investing.com Canada
Lucid Capital Markets initiates Passage Bio stock with Buy rating - Investing.com India
Passage Bio, Inc. (PASG) Analyst Insights, Price Targets & Recommendations - Yahoo! Finance Canada
How Passage Bio Inc. stock compares to market leadersInsider Selling & AI Powered Market Trend Analysis - newser.com
Is Passage Bio Inc. stock bottoming out2025 Volatility Report & Proven Capital Preservation Tips - newser.com
Passage Bio Pushes Toward Key 2026 Milestones as Gene Therapy Program Accelerates - MSN
How Passage Bio Inc. stock reacts to Fed rate cuts2025 Momentum Check & Low Risk High Win Rate Picks - newser.com
Applying chart zones and confluence areas to Passage Bio Inc.2025 Bull vs Bear & Safe Swing Trade Setups - newser.com
Passage Bio Inc Stock (PASG) Financials Data
Revenue
Net Income
Cash Flow
EPS
28.63%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):